The synthetic cannabinoid WIN 55212-2 differentially modulates thigmotaxis but not spatial learning in adolescent and adult animals

Neuroscience Letters

Volumn 487, Issue 3, 2011, Pages 411-414

  Acheson, Shawn K ^a,b   Moore, Nicole L T ^a   Kuhn, Cynthia M ^a   Wilson, Wilkie A ^a,b   Swartzwelder, H Scott ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Adolescence; Cannabinoid; Thigmotaxis; WIN 55212 2

Indexed keywords

11 HYDROXYDRONABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ENDOCANNABINOID;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; LEARNING; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

AGE FACTORS; ANIMALS; BENZOXAZINES; BRAIN; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; MALE; MAZE LEARNING; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78650518686     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.10.067     Document Type: Article

References (46)

1. Abel E.L. A Comprehensive Guide to the Cannabis Literature 1979, Greenwood Press, Westport, CN.
2. Adams I.B., Martin B.R. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996, 91:1585-1614.
3. Aggarwal S.K., Carter G.T., Sullivan M.D., ZumBrunnen C., Morrill R., Mayer J.D. Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. J. Opioid Manage. 2009, 5:153-168.
4. Bagshaw S.M., Hagen N.A. Medical efficacy of cannabinoids and marijuana: a comprehensive review of the literature. J. Palliat. Care 2002, 18:111-122.
5. Beiko J., Lander R., Hampson E., Boon F., Cain D.P. Contribution of sex differences in the acute stress response to sex differences in water maze performance in the rat. Behav. Brain Res. 2004, 151:239-253.
6. Berry E.M., Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacol. Ther. 2002, 95:185-190.
7. Biala G., Kruk M., Budzynska B. Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test. J. Physiol. Pharmacol. 2009, 60:113-122.
8. Burns T.L., Ineck J.R. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain. Ann. Pharmacother. 2006, 40:251-260.
9. Castellano C., Rossi-Arnaud C., Cestari V., Costanzi M. Cannabinoids and memory: animal studies. Curr. Drug Targets CNS Neurol. Disord. 2003, 2:389-402.
10. Cha Y.M., Jones K.H., Kuhn C.M., Wilson W.A., Swartzwelder H.S. Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behav. Pharmacol. 2007, 18:563-569.
11. Cha Y.M., White A.M., Kuhn C.M., Wilson W.A., Swartzwelder H.S. Differential effects of delta9-THC on learning in adolescent and adult rats. Pharmacol. Biochem. Behav. 2006, 83:448-455.
12. Chaperon F., Thiebot M.H. Behavioral effects of cannabinoid agents in animals. Crit. Rev. Neurobiol. 1999, 13:243-281.
13. Choleris E., Thomas A.W., Kavaliers M., Prato F.S. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci. Biobehav. Rev. 2001, 25:235-260.
14. Da S., Takahashi R.N. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26:321-325.
15. Eisenstein T.K., Meissler J.J., Wilson Q., Gaughan J.P., Adler M.W. Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. J. Neuroimmunol. 2007, 189:17-22.
16. Farquhar-Smith W.P., Rice A.S. A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. Anesthesiology 2003, 99:1391-1401.
17. Fernandez-Espejo E., Viveros M.P., Nunez L., Ellenbroek B.A., Rodriguez de Fonseca F. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology 2009, 206:531-549.
18. Ganon-Elazar E., Akirav I. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J. Neurosci. 2009, 29:11078-11088.
19. Grossen N.E., Kelley M.J. Species-specific behavior and acquisition of avoidance behavior in rats. J. Comp. Physiol. Psychol. 1972, 81:307-310.
20. Hampson R.E., Deadwyler S.A. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J. Neurosci. 2000, 20:8932-8942.
21. Harris A.P., D'Eath R.B., Healy S.D. Environmental enrichment enhances spatial cognition in rats by reducing thigmotaxis (wall hugging) during testing. Anim. Behav. 2009, 77:1459-1464.
22. Herrero A.I., Sandi C., Venero C. Individual differences in anxiety trait are related to spatial learning abilities and hippocampal expression of mineralocorticoid receptors. Neurobiol. Learn. Mem. 2006, 86:150-159.
23. Kavaliers M., Choleris E. Antipredator responses and defensive behavior: ecological and ethological approaches for the neurosciences. Neurosci. Biobehav. Rev. 2001, 25:577-586.
24. Lichtman A.H., Martin B.R. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 1996, 126:125-131.
25. Mishima K., Egashira N., Hirosawa N., Fujii M., Matsumoto Y., Iwasaki K., Fujiwara M. Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats. Jpn. J. Pharmacol. 2001, 87:297-308.
26. Naderi N., Haghparast A., Saber-Tehrani A., Rezaii N., Alizadeh A.-M., Khani A., Motamedi F. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice. Pharmacol. Biochem. Behav. 2008, 89:64-75.
27. Nakamura E.M., da Silva E.A., Concilio G.V., Wilkinson D.A., Masur J. Reversible effects of acute and long-term administration of delta-9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend. 1991, 28:167-175.
28. Patel S., Hillard C.J. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J. Pharmacol. Exp. Ther. 2006, 318:304-311.
29. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145:5431-5438.
30. Ranganathan M., D'Souza D. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl). 2006, 188:425-444.
31. Rice A.S., Farquhar-Smith W.P., Nagy I. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot. Essent. Fatty Acids 2002, 66:243-256.
32. Robinson L., Goonawardena A.V., Pertwee R.G., Hampson R.E., Riedel G. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. Br. J. Pharmacol. 2007, 151:688-700.
33. Rubino T., Sala M., Vigano D., Braida D., Castiglioni C., Limonta V., Guidali C., Realini N., Parolaro D. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral [Delta]9-tetrahydrocannabinol in rats. Neuropsychopharmacology 2007, 32:2036-2045.
34. Rubino T., Vigano D., Realini N., Guidali C., Braida D., Capurro V., Castiglioni C., Cherubino F., Romualdi P., Candeletti S., Sala M., Parolaro D. Chronic Delta(9)-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 2008, 33:2760-2771.
35. Scherma M., Medalie J., Fratta W., Vadivel S.K., Makriyannis A., Piomelli D., Mikics E., Haller J., Yasar S., Tanda G., Goldberg S.R. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Neuropharmacology 2008, 54:129-140.
36. Schneider M., Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 2003, 28:1760-1769.
37. Schneider M., Schomig E., Leweke F.M. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addict. Biol. 2008, 13:345-357.
38. Schramm-Sapyta N.L., Cha Y.M., Chaudhry S., Wilson W.A., Swartzwelder H.S., Kuhn C.M. Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats. Psychopharmacology 2007, 191:867-877.
39. Snihur A.W.K., Hampson E., Cain D.P. Estradiol and corticosterone independently impair spatial navigation in the Morris water maze in adult female rats. Behav. Brain Res. 2008, 187:56-66.
40. Suenaga T., Kaku M., Ichitani Y. Effects of intrahippocampal cannabinoid receptor agonist and antagonist on radial maze and T-maze delayed alternation performance in rats. Pharmacol. Biochem. Behav. 2008, 91:91-96.
41. Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend. 1996, 42:201-207.
42. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 1989, 31:959-962.
43. Varvel S.A., Anum E., Niyuhire F., Wise L.E., Lichtman A.H. Delta(9)-THC-induced cognitive deficits in mice are reversed by the GABA(A) antagonist bicuculline. Psychopharmacology 2005, 178:317-327.
44. Varvel S.A., Hamm R.J., Martin B.R., Lichtman A.H. Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology 2001, 157:142-150.
45. Wegener N., Kuhnert S., Thuns A., Roese R., Koch M. Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats. Psychopharmacology 2008, 198:375-385.
46. Wise L.E., Thorpe A.J., Lichtman A.H. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. Neuropsychopharmacology 2009, 34:2072-2080.